Elena Miglioranza

Elena Miglioranza

Auto-generated profile, based on publicly available information

Elena Miglioranza

DIBINEM, University of Bologna, Bologna, Italy

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2025 in PLOS ONE
Verified
Journal Article
Open access
PDF file
EMElena Miglioranza
Elena Miglioranza
LRLaura Rullo
Laura Rullo
SASara Alvente
Sara Alvente
SBStefano Bastianini
Stefano Bastianini
DCDario Coraci
Dario Coraci
Chiara BerteottiChiara Berteotti
Chiara Berteotti
Early-life exposure to environmental stressors may increase the risk of disease later in life. Chlorpyrifos (CPF), a widely used pesticide and acetylcholinesterase inhibitor, can cross the placental barrier and can be found in breast milk, leading to excessive cholinergic stimulation. Acetylcholine is involved in sleep and respiratory regulation. The main objective of this study was to investigate whether perinatal CPF exposure affects sleep-related breathing together with promotion of neuroinflammatory processes in adulthood. To explore these effects, CPF (5 mg/kg/day) or vehicle was administered orally to dams from mating to weaning. The offspring were not directly treated. At 17–18 weeks of age, male and female offspring underwent electroencephalographic and electromyographic electrode implantation to monitor sleep-wake cycles. Recordings were conducted over 48 hours in home cages, and for 7 hours in a plethysmographic chamber to assess sleep-related breathing pattern. At the end of recordings, hippocampal tissues were collected for gene expression analysis via real-time PCR. Results revealed that CPF perinatal exposure increased sighs and apneas during sleep in adult mice, especially in female. Additionally, expression of pro-inflammatory cytokines was upregulated while expression of peroxisome proliferator-activated receptor genes was downregulated in the hippocampus of female mice born to CPF-treated dams. These findings suggest that perinatal CPF exposure can induce long-lasting alterations in sleep-related respiratory patterns and hippocampal inflammatory responses, with a sex-specific susceptibility—females being more affected. This highlights the perinatal period as a critical window of vulnerability to environmental toxicants such as pesticides. The results support the hypothesis that adult sleep and brain inflammation phenotypes may be modulated by early-life chemical exposures during pregnancy and lactation.

1 March 2026 in IEEE Journal of Microwaves
Verified
Journal Article
Open access
Giacomo PaoliniGiacomo Paolini
Giacomo Paolini
GBGiulia Battistini
Giulia Battistini
EAElisa Augello
Elisa Augello
SBStefano Bastianini
Stefano Bastianini
CBChiara Berteotti
Chiara Berteotti
ACAlessandra Costanzo
Alessandra Costanzo
Obstructive sleep apnea (OSA) is a widespread sleep-related breathing disorder linked to cardiovascular and cognitive complications. Although continuous positive airway pressure (CPAP) remains the standard therapy, poor patient adherence limits its effectiveness. Hypoglossal nerve stimulation is a promising alternative, and optogenetic activation offers superior spatiotemporal precision. However, before clinical use, this approach requires thorough validation in animal models using platforms that preserve natural behavior. This work proposes a fully wireless alternative to conventional optogenetic platforms which rely on tethered optical fibers, restricting the animal's mobility, inducing tissue inflammation, and limiting experimental flexibility. Fully implantable, miniaturized systems with wireless power transfer (WPT) and control capabilities address the need for reduced invasiveness, enabling natural behavior and long-term studies. We present the design and the in vivo validation of a battery-free, wireless optogenetic platform for in vivo studies on small laboratory mice, designed to minimize device size, weight, and invasiveness. A conformal WPT system of inductive resonant transmitting coils at 13.56 MHz is proposed to be integrated into the laboratory cage hosting the mice. A miniaturized, lightweight, and flexible receiving system (weighing less than 0.6 g) is designed to be implanted on the back of the mouse in a saddle-like configuration. The implanted device hosts the rectification circuitry, used to drive a microscale light-emitting diode (LED) positioned over the hypoglossal nuclei. In this way, optogenetic stimulation without fiber-optic tethers is obtained. Full-wave electromagnetic simulations and experimental validation are first carried out to assess the WPT link performance, demonstrating high tolerance to relative translational and angular displacement between the transmitting and receiving coils, and stable harvested power across the cage volume. For a transmitted power of 1.5 W, a minimum DC power of 20 mW has been obtained in the worst-case position of the mouse inside the cage, sufficient for the LED operation. Finally, in vivo experiments are presented, confirming not only the LED activation but also the hypoglossal nerve stimulation, fully compliant with the radiant flux requirements for optogenetic neurostimulation under realistic conditions. These results demonstrate the feasibility and robustness of the proposed WPT system for untethered, battery-free optogenetic stimulation in lightweight murine models with OSA, providing a platform for preclinical neuroscience research, paving the way toward next-generation low-invasiveness neuromodulation strategies.